Basic Drug Info
Drug Name:Buprenorphine Hydrochloride
Manufacturer:Hospira, Inc.
Other Info:CIIIRx only

Clinical Trials:

Indications and Usage
Buprenorphine hydrochloride injection is indicated for the relief of moderate to severe pain.
Buprenorphine hydrochloride should not be administered to patients who have been shown to be hypersensitive to the drug.
Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.


Impaired Respiration: As with other potent opioids, clinically significant respiratory depression may occur within the recommended dose range in patients receiving therapeutic doses of buprenorphine.

Buprenorphine hydrochloride should be used with caution in patients with compromised respiratory function (e.g., chronic obstructive pulmonary disease, cor pulmonale, decreased respiratory reserve, hypoxia, hypercapnia, or preexisting respiratory depression).

Particular caution is advised if buprenorphine is administered to patients taking or recently receiving drugs with CNS/respiratory depressant effects.

In patients with the physical and/or pharmacological risk factors above, the dose should be reduced by approximately one-half.NALOXONE MAY NOT BE EFFECTIVE IN REVERSING THE RESPIRATORY DEPRESSION PRODUCED BY BUPRENORPHINE. THEREFORE, AS WITH OTHER POTENT OPIOIDS, THE PRIMARY MANAGEMENT OF OVERDOSE SHOULD BE THE RE-ESTABLISHMENT OF ADEQUATE VENTILATION WITH MECHANICAL ASSISTANCE OF RESPIRATION, IF REQUIRED.Interaction with Other Central Nervous System Depressants: Patients receiving buprenorphine hydrochloride in the presence of other narcotic analgesics, general anesthetics, antihistamines, benzodiazepines, phenothiazines, other tranquilizers, sedative/hypnotics or other CNS depressants (including alcohol) may exhibit increased CNS depression.

When such combined therapy is contemplated, it is particularly important that the dose of one or both agents be reduced.Head Injury and Increased Intracranial Pressure: Buprenorphine hydrochloride, like other potent analgesics, may itself elevate cerebrospinal fluid pressure and should be used with caution in head injury, intracranial lesions and other circumstances where cerebrospinal pressure may be increased. Buprenorphine can produce miosis and changes in the level of consciousness which may interfere with patient evaluation.Use In Ambulatory Patients: Buprenorphine may impair the mental or physical abilities required for the performance of potentially dangerous tasks such as driving a car or operating machinery.

Therefore, buprenorphine hydrochloride should be administered with caution to ambulatory patients who should be warned to avoid such hazards.Use in Narcotic-Dependent Patients: Because of the narcotic antagonist activity of buprenorphine, use in the physically dependent individual may result in withdrawal effects.
Branded Drugs
The following US Branded drugs contain Buprenorphine Hydrochloride




This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.